|
|
Regulation of advertisements in pharmaceutical industry
Metelka, Jan ; Patěk, Daniel (advisor) ; Rozehnal, Aleš (referee)
Abstract, Jan Metelka The main aim of this diploma thesis was to firstly explain the field of human pharmaceuticals and regulation of advertisement regarding them, from the general point of view and then in details. In order to achieve this it was required to define advertisement and pharmaceuticals because these terms and crucial for the whole thesis. Both definitions may be off the scope of this text however it plays an important role in understanding all necessary issues. Advertisements in pharmaceutical industry have some specifics as described in chapter 2. There are two kinds of recipients - experts (doctors and pharmacists) and ordinary people (mostly patients). Every kind is special and regulated in a different way. Third chapter described all steps in administrative proceedings related to Act on Advertisement, forming a public branch of law against unfair competition. It summarises and divides all misdemeanours, statistically describes how often they occur and deeply analyses possible breaches of Act on Advertisement. The main part of this thesis is Chapter seven, dealing with unfair competition in private law, as mentioned in early chapters, however here it is specifically described how to apply the general clause and the more important kinds of unfair competition such as deceptive adverts and...
|
|
|
Regulation of advertisements in pharmaceutical industry
Metelka, Jan ; Patěk, Daniel (advisor) ; Rozehnal, Aleš (referee)
Abstract, Jan Metelka The main aim of this diploma thesis was to firstly explain the field of human pharmaceuticals and regulation of advertisement regarding them, from the general point of view and then in details. In order to achieve this it was required to define advertisement and pharmaceuticals because these terms and crucial for the whole thesis. Both definitions may be off the scope of this text however it plays an important role in understanding all necessary issues. Advertisements in pharmaceutical industry have some specifics as described in chapter 2. There are two kinds of recipients - experts (doctors and pharmacists) and ordinary people (mostly patients). Every kind is special and regulated in a different way. Third chapter described all steps in administrative proceedings related to Act on Advertisement, forming a public branch of law against unfair competition. It summarises and divides all misdemeanours, statistically describes how often they occur and deeply analyses possible breaches of Act on Advertisement. The main part of this thesis is Chapter seven, dealing with unfair competition in private law, as mentioned in early chapters, however here it is specifically described how to apply the general clause and the more important kinds of unfair competition such as deceptive adverts and...
|
|
|
Switching medicines containing pseudoephedrine in OTC group limited
Koníčková, Veronika ; Lešetický, Ondřej (advisor) ; Jankůj, Miroslav (referee)
Goals: Prepare a case study on the transition to the new OTC medicines groups with restrictions. To evaluate the positives and negatives, which brought the introduction of the group - with OTC restrictions. Pick up generally applicable principles and specify non-functional parts of the system. Method: For data processing method was applied theoretical research. Literature was searched in the database of the Czech National Library - Klementinum, WHO database, TRIBUNE and interfaces of News portals. The instrumental case study was processed for a detailed insight into the issues. The case study is also based on the analysis of the legal framework of the Czech Republic. The documents provided by SÚKL are used for financial analysis. As another method the stakeholder analysis was used - analysis of opinions of people involved in the drug policy. Results: The case study shows that switching medicines containing PSE to the limited group of OTC to prevent producers of drugs buing drugs in Czech pharmacies, but it did not reduce the amount of drugs produced in the country. Producers started to import precursors from abroad. The whole new system established in 2009 was correct in principle, but failed in practice. State Institute for Drug Control or other stakeholders in drug policy have not been able to resolve the ensuing complications.
|
|
|
Pharmacovigilance of Medicines
Dvořáková, Ilona ; Lešetický, Ondřej (advisor) ; Filipová, Markéta (referee)
The objective of my Bachelor thesis is to analyse development of pharmacovigilance and adverse event reporting in the Czech Republic and other countries, with a focus on the changes in the number of adverse event reports over the last thirty years in Czech Republic and comparison with development of adverse event reports in other countries and prediction the possible trends in adverse event reporting in the future. My Bachelor thesis will also contain definitions of adverse events in accordance with the Medicinal Products Act No. 378/2007, as well as a detailed description of the adverse event reporting procedure, the persons who are obliged to report adverse events, and the systems in place for reporting adverse events by pharmaceutical companies. I will also include a chapter on the history of pharmacovigilance in the Czech Republic and in other countries and a description of how the Uppsala Monitoring Centre, WHO's centre for monitoring adverse events, works. A section will be dedicated to pharmacovigilance tools used by State Institute for Drug Control, with a detailed focus on selected side effects of drugs reported in the recent years. In the final chapter of my Bachelor thesis, I will map the development of the number of adverse event reports in the Czech Republic and in the other countries with the aim of predicting potential trends in adverse event reporting in the future.
|
|
|
Distribution of Healing Substances with Pseudoephedrine
Kučerová, Kateřina ; Lešetický, Ondřej (advisor) ; Střítecký, Rudolf (referee)
The thesis is focused on the distribution of medicinal products containing the active ingredient pseudoephedrine. These medicines are misused because of its active substance to produce an addictive methamphetamine (meth). The aim is to monitor the development restrictions associated with those drugs in the past, concern and characterize the current status of this issue. In the thesis, the theoretical knowledge of economics and drug problems. The practical part deals with the historical development of restrictions and evaluation of the status quo.
|
|
|
Commercial Communication in Czech Pharmaceutical Industry
Kadlecová, Barbora ; Mikeš, Jiří (advisor) ; Hrubá, Kamila (referee)
Thesis titled Commercial communications in czech pharmaceutical industry is about how to use marketing communication tools (advertising, public relations, sales promotion, personal selling, etc.) in the pharmaceutical industry. A specific feature of pharmaceutical marketing is separate communication to public (patients) and to professionals (doctors) which requires using different communication messages and also different channels to each target group. Pharmaceutical marketing is regulated by advertising law, by the Council for Radio and TV Broadcasting and by the provisions of the State Institute for Drug Control which control the ways how two target groups are addressed. Possible marketing tools are described from both theoretical (legal) and also practical (marketing communication of specific pharmaceutical company) terms.
|
guest ::
